NADAC acquisition cost data for FORFIVO XL 450 MG TABLET. This is a brand-name medication — generic alternatives may be available at lower prices.
| Generic Name | bupropion hydrochloride |
| Brand Name | Forfivo XL |
| Manufacturer | Upsher-Smith Laboratories, LLC |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Pharmacologic Class | Aminoketone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 52427057530 | $14.76 | 2022-09-21 | Rx |
| 52427057530 | $14.76 | 2022-09-21 | Rx |
| 52427057530 | $14.76 | 2022-09-21 | Rx |
| 52427057530 | $14.76 | 2022-09-21 | Rx |
| 52427057530 | $14.76 | 2022-09-21 | Rx |
| 52427057530 | $14.76 | 2022-09-21 | Rx |
| 52427057530 | $14.76 | 2022-09-21 | Rx |
| 52427057530 | $14.76 | 2022-09-21 | Rx |
| 52427057530 | $14.76 | 2022-09-21 | Rx |
| 52427057530 | $14.76 | 2022-09-21 | Rx |
Generic: Bupropion HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $1.1M | 2,063 | 497 | $14.55 |
| 2020 | $781.8K | 1,333 | 276 | $14.42 |
| 2021 | $634.6K | 979 | 220 | $15.05 |
| 2022 | $544.2K | 766 | 180 | $15.58 |
| 2023 | $413.6K | 581 | 150 | $15.73 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.